Avantax Advisory Services Inc. lifted its position in shares of Centene Co. (NYSE:CNC – Free Report) by 32.9% during the fourth quarter, HoldingsChannel reports. The firm owned 16,460 shares of the company’s stock after purchasing an additional 4,077 shares during the quarter. Avantax Advisory Services Inc.’s holdings in Centene were worth $997,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. Capital Advisors Ltd. LLC boosted its position in Centene by 75.3% in the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock valued at $25,000 after buying an additional 177 shares during the last quarter. Rialto Wealth Management LLC purchased a new position in Centene in the fourth quarter valued at about $30,000. OFI Invest Asset Management purchased a new stake in Centene during the 4th quarter worth approximately $33,000. SRS Capital Advisors Inc. raised its position in shares of Centene by 73.4% in the 4th quarter. SRS Capital Advisors Inc. now owns 631 shares of the company’s stock valued at $38,000 after purchasing an additional 267 shares in the last quarter. Finally, Riverview Trust Co grew its position in shares of Centene by 172.7% during the fourth quarter. Riverview Trust Co now owns 758 shares of the company’s stock worth $46,000 after buying an additional 480 shares in the last quarter. 93.63% of the stock is owned by institutional investors and hedge funds.
Centene Trading Down 0.7 %
Shares of NYSE:CNC opened at $59.26 on Thursday. The company has a quick ratio of 1.10, a current ratio of 1.11 and a debt-to-equity ratio of 0.70. The company’s 50-day moving average price is $60.39 and its 200 day moving average price is $63.43. The company has a market cap of $29.40 billion, a PE ratio of 9.50, a P/E/G ratio of 0.80 and a beta of 0.40. Centene Co. has a fifty-two week low of $55.03 and a fifty-two week high of $80.59.
Analyst Upgrades and Downgrades
CNC has been the topic of a number of research analyst reports. Wells Fargo & Company reduced their price objective on shares of Centene from $76.00 to $72.00 and set an “overweight” rating on the stock in a research note on Friday, February 14th. Jefferies Financial Group cut shares of Centene from a “hold” rating to an “underperform” rating and reduced their price target for the stock from $68.00 to $52.00 in a research report on Tuesday, December 10th. StockNews.com lowered Centene from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 6th. UBS Group upgraded Centene from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $79.00 to $80.00 in a research report on Friday, December 13th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $90.00 price objective on shares of Centene in a research note on Wednesday, December 11th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $79.92.
Read Our Latest Stock Analysis on Centene
Centene Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Further Reading
- Five stocks we like better than Centene
- Learn Technical Analysis Skills to Master the Stock Market
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Compound Interest and Why It Matters When Investing
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Insider Buying Explained: What Investors Need to Know
- D-Wave and Quantum Supremacy: Implications For Investors
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.